Literature DB >> 15916731

Gene expression profile of amyloid beta protein-injected mouse model for Alzheimer disease.

Ling-na Kong1, Ping-ping Zuo, Liang Mu, Yan-yong Liu, Nan Yang.   

Abstract

AIM: To investigate the gene expression profile changes in the cerebral cortex of mice injected icv with amyloid beta-protein (Abeta) fragment 25-35 using cDNA microarray.
METHODS: Balb/c mice were randomly divided into a control group and Abeta-treated group. The Morris water maze test was performed to detect the effect of Abeta-injection on the learning and memory of mice. Atlas Mouse 1.2 Expression Arrays containing 1176 genes were used to investigate the gene expression pattern of each group.
RESULTS: The gene expression profiles showed that 19 genes including TBX1, NF-kB, AP-1/c-Jun, cadherin, integrin, erb-B2, and FGFR1 were up-regulated after 2 weeks of icv administration of Abeta; while 12 genes were down-regulated, including NGF, glucose phosphate isomerase 1, AT motif binding factor 1, Na+/K+-ATPase, and Akt.
CONCLUSIONS: The results provide important leads for pursuing a more complete understanding of the molecular events of Abeta-injection into mice with Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916731     DOI: 10.1111/j.1745-7254.2005.00129.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  12 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Graphene quantum dots rescue protein dysregulation of pancreatic β-cells exposed to human islet amyloid polypeptide.

Authors:  Ava Faridi; Yunxiang Sun; Monika Mortimer; Ritchlynn R Aranha; Aparna Nandakumar; Yuhuan Li; Ibrahim Javed; Aleksandr Kakinen; Qingqing Fan; Anthony W Purcell; Thomas P Davis; Feng Ding; Pouya Faridi; Pu Chun Ke
Journal:  Nano Res       Date:  2019-09-26       Impact factor: 8.897

3.  Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.

Authors:  Valentine Lahmy; Johann Meunier; Susanna Malmström; Gaelle Naert; Laurent Givalois; Seung Hyun Kim; Vanessa Villard; Alexandre Vamvakides; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2013-03-14       Impact factor: 7.853

4.  Use of copper and insulin-resistance to accelerate cognitive deficits and synaptic protein loss in a rat Abeta-infusion Alzheimer's disease model.

Authors:  Aynun N Begum; Fusheng Yang; Edmond Teng; Shuxin Hu; Mychica R Jones; Emily R Rosario; Walter Beech; Beverly Hudspeth; Oliver J Ubeda; Greg M Cole; Sally A Frautschy
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

5.  Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.

Authors:  Marjana Brkic; Sriram Balusu; Elien Van Wonterghem; Nina Gorlé; Iryna Benilova; Anna Kremer; Inge Van Hove; Lieve Moons; Bart De Strooper; Selma Kanazir; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  J Neurosci       Date:  2015-09-16       Impact factor: 6.167

6.  Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability.

Authors:  Xinkun Wang; Mary L Michaelis; Elias K Michaelis
Journal:  Curr Genomics       Date:  2010-12       Impact factor: 2.236

7.  Ranking candidate disease genes from gene expression and protein interaction: a Katz-centrality based approach.

Authors:  Jing Zhao; Ting-Hong Yang; Yongxu Huang; Petter Holme
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

Review 8.  ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice.

Authors:  Xin Liu; Michael Dobbie; Rob Tunningley; Belinda Whittle; Yafei Zhang; Lars M Ittner; Jürgen Götz
Journal:  J Biomed Biotechnol       Date:  2011-12-15

9.  Amyloid-beta induced CA1 pyramidal cell loss in young adult rats is alleviated by systemic treatment with FGL, a neural cell adhesion molecule-derived mimetic peptide.

Authors:  Nicola J Corbett; Paul L Gabbott; Boris Klementiev; Heather A Davies; Frances M Colyer; Tatiana Novikova; Michael G Stewart
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

10.  Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells.

Authors:  Susanne Schüler-Toprak; Christoph Moehle; Maciej Skrzypczak; Olaf Ortmann; Oliver Treeck
Journal:  BMC Cancer       Date:  2017-05-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.